Skip to main content
Clinical Trials/NL-OMON55040
NL-OMON55040CompletedPhase 4

The STARS-Trial: To Assess Stent Apposition by Optical Coherence Tomography (OCT) of the Svelte Sirolimus-Eluting Coronary Stent Systems (IDS and RX) Compared to the Abbott Vascular Xience Everolimus-Eluting Coronary Stent System for the Treatment of Atherosclerotic Lesions in a Randomized Study - STARS

Amphia Ziekenhuis0 sites250 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
250

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Subject has symptomatic coronary artery disease with objective evidence of
  • ischemia or silent ischemia

Exclusion Criteria

  • - Subject has cardiogenic shock, hemodynamic instability requiring inotropic or
  • mechanical circulatory support, intractable ventricular arrhythmia, or ongoing
  • intractable angina;

Investigators

Sponsor
Amphia Ziekenhuis

Similar Trials